Albert Cha is a Chairman at Ascendis Pharma, whose known portfolio counts 1 company.
Is Albert Cha a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Chairman at Ascendis Pharma, whose known portfolio counts 1 company
- Visen Pharmaceuticals
Investor Profile
Albert Cha is listed against sector Healthcare, and focus areas Biotech, Drug Discovery, MedTech and Pharma in the database.
Albert Cha is listed for Series A and Series B rounds in the database.
What the affiliated firm has backed is the closest available signal on whether Albert Cha is worth approaching.
Colleagues at Ascendis Pharma
Frequently asked questions
Who is Albert Cha?
Albert Cha is a corporate venture investor based in United States, listed as Chairman at Ascendis Pharma. The known portfolio of that firm is one company. That portfolio belongs to the firm, not to Albert Cha personally.
What does Albert Cha invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery, MedTech and Pharma. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Albert Cha invest at?
Ascendis Pharma is listed for Series A and Series B rounds in the database, and Albert Cha is listed there as Chairman. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Albert Cha listed at?
Albert Cha is listed as Chairman at Ascendis Pharma. 2 other people in the database share a firm with Albert Cha.
How do I contact Albert Cha?
An email address, a phone number and a LinkedIn page are on file for Albert Cha. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal